HemoGenyx Pharmaceuticals PLCLSE: HEMO

HemoGenyx Pharmaceuticals: Change of Registered Office

· Issued by HemoGenyx Pharmaceuticals PLC

1 July 2022  

Hemogenyx Pharmaceuticals plc  

("Hemogenyx Pharmaceuticals" or the "Company")

Change of Registered Office

Hemogenyx Pharmaceuticals plc announces that its registered office address has changed with immediate effect to 6th Floor,60 Gracechurch Street, London, EC3V 0HR,United Kingdom.

Enquiries:

Hemogenyx Pharmaceuticals plc

https://hemogenyx.com

Dr Vladislav Sandler, Chief Executive Officer & Co-Founder

[email protected]

Peter Redmond, Director

[email protected]

SP Angel Corporate Finance LLP

Tel: +44 (0)20 3470 0470

Matthew Johnson, Vadim Alexandre, Adam Cowl

Peterhouse Capital Limited

Tel: +44 (0)20 7469 0930

Lucy Williams, Duncan Vasey, Charles Goodfellow

HemoGenyx Pharmaceuticals PLC on 6ix

Earlier from HemoGenyx Pharmaceuticals

Later from HemoGenyx Pharmaceuticals

All HemoGenyx Pharmaceuticals news releases